SlideShare una empresa de Scribd logo
1 de 17
Descargar para leer sin conexión
Using a single multifunctional organocatalyst
         in a single-step construction of
bispirooxindoles with 3 quaternary stereocentres
                                       LY-NGUYEN Hai Du - 31/10




      Tan, B., Candeias, N. R, & Barbas, C. F. Nat. Chem. 2011, 3, 473
BISPIROOXINDOLES, WHY?
 Spirocyclicooxindole scaffold
                                                                                                                               F
                                                                                                                     Cl
                       H                                    H
                               N                    H               N
              OH                                                                       N
                                                                                                                               HN
                                                                                                                                             NH
                           NHMe                                 NO2                                     H H
                                                                                                          N                                   O
                           O                                    O                          OMeN                                        N
                                                                                   N                                    Cl
                   N                   MeO              N               HO                                                             H
                   H                                                               H

              O                              O
      O
                                                                                  Strychnofoline                               NITD609
          Citrinadin B                     Cyclopiamine B

 Sructural features: > = 1 C */ enantiomerically pure backbone => efficient asymmetric synthetic methods

IN REALITY???
Few transformations meet this requirement
                                                                                       Ar
Cycloaddition processes                                                                    O       O
                                                                                               P                          R4
                                                                                                   OH
                               R2                                                          O
                                                                                                                                   NH
                                                                                       Ar
                                                                                                                   R2                CO2R6
                                                   R5
                                                                             Ar = -Naphthyl                                          R5
R4 CHO        R1                       O                                                                      R1                    O
                                             H2N        CO2R6                 CH2Cl2 ,RT,                                    N
                               N
                                R3                                                                                            R3
                                                                                                                   Up to 98% ee
 Intramolecular Heck reactions
                       CO2Me                                                 Cyclohexen                                 CO2Me
                                                                         Pd(OAc)2, (R ) - BINAP

                                   I                                         Ag2CO3, NMP,600C
                                                                                                                      H
                                                                                                                   About 46% ee
Inherent benefits of using organic molecules as catalysts ?

- available from bio-matter
- intensitive to moisture and air
- non-toxic
- inexpensive and operationally easy to handle
- rich ???
Generic mode of activation commonly used in organocatalysis
Iminium catalysis                                                         Enamine catalysis

      O              N+                   N+         more electrophilic              O                       N
                                                                                                NH
                    H H                              H                       H

          R'        - H2O                      R'                                         R'   - H2O             R'
R                                R                                           R                         R
                                                     more acidic                                           more nucleophilic

                                more electrophilic



                                                    H-bonding catalysis
                                                                                 S
                                                              S
                                     X                                       N       N
                                                         NH       NH
                                                                             H       H
                                R        R'                                      X
                            X= O,NR
                            R,R',R''= alkyl, aryl                            R       R'

                                                                          more electrophilic
Inherent benefits of using organic molecules as catalysts ?

- available from bio-matter
- intensitive to moisture and air
- non-toxic
- inexpensive and operationally easy to handle
- rich ???
Generic mode of activation commonly used in organocatalysis
Iminium catalysis                                                         Enamine catalysis

      O              N+                   N+         more electrophilic              O                       N
                                                                                                NH
                    H H                              H                       H

          R'        - H2O                      R'                                         R'   - H2O             R'
R                                R                                           R                         R
                                                     more acidic                                           more nucleophilic

                                more electrophilic



                                                    H-bonding catalysis
                                                                                 S
                                                              S
                                     X                                       N       N
                                                         NH       NH
                                                                             H       H
                                R        R'                                      X
                            X= O,NR
                            R,R',R''= alkyl, aryl                            R       R'

                                                                          more electrophilic
Cinchona alkaloid derivatives                                                        activate
                                                                                   electrophile
                                                    OMe                                                                        OMe
                                                 6'                                                                            6'
                                                                   OH                                         OH
                                                             4'                N                  N               4'
                                                                   9       8                          8       9
                                                    N                   H                             H                        N

                                                                 Quinidine                            Quinie
                                                                                    activate                                               activate
                                                                                   nucleophile                                           electrophile
                               activate
                             electrophile
   OH                                                                  OH                                 OH                                            OH
  6'                                                                    6'                            6'                                            6'

               OR                                       OR                                                                 O                                          NH2
          4'             N                  N               4'                                                     4'                N                           4'             N
               9     8                          8       9                                                                  9                                          9     8
                                                                                                                               8
   N                H                            H                     N                                  N                                             N                 H

           QD-1                                 Q-1                                                                                       activate                              QD-3
                              activate                                                                                 QD-2              nucleophile
                             nucleophile

Deng et al., 2004
  Addition 1,4 of malonates to nitroolefins                                                               COOMe                    COOMe
               NO2                                                      QD-1/Q-1(10mol%)                                                       97-99% yield,
   R                         COOMe              COOMe                                                                                NO2       93-96% ee
                                                                                       0
                                                                           THF,-20 C,36h                               R
R=aryl, heteroaryl
                                                                             O                O                                                             OH        O
  Baylis-Hilman reaction                                                                                                   QD-2
                                                                    R1             H               R2                                             R1                      R2
Guofu Zhong et al. , 2008
                                    R1                                                                                                              O        O
                                            O                      O
 Michael-Henry reaction                                                                                                    QD-3                                       O R1
                                                                                                  NO2                                                                 R             85% =94% yield
                                     O                                             R                                                                                                up to 99 .99% ee
                                                                                                                                                               NO2                  up to 99:1 dr
                                            O                                                                                                                OH
3-substituted oxindoles - efficient Michael donors                                                                          F3C

 Maruoka et al, 2009
                                                                                           O              Catalyst                               CF3

                                                                                                                                       Br
                                                                                                                                            Bu
                                       O                                                                                               P
                                              Catalyst (1-3mol %)
                                                    Toluen                                                                                 Bu
                    O                                                                      O
                                              Potassium benzoate
              N                                 2-18h,-60-00 C
                                                                                     N                                                           CF3
              Boc                                                                    Boc
                                                                          >96% yield, 90-99%ee                                   F3C

     Barbas et al, 2009                                                              R1                   Catalyst
                                                                                                                                 S
           R                                                                     R             NO2
                                                                                                                                  Ar
                                                                                                                              NH NH
                                                  Catalyst (10 mol %)
                                       NO2                                                 O                            N
                    O       R1                                                                            Ar   (CH2)3       (CH2)3 Ar                  CF3
                                              CHCl3, 24h, -200 C
              N                                                                     N
                                                                                                                                 Ar=
              Boc                                                                Boc
 R=alkyl                    R1=aryl, heteroaryl                          >90%yield, >90% ee                                                            CF3

 Methyleneidolinones - highly reactive Michael acceptors
 Chung Chen et al, 2009
                                                                                                                 Catalyst
        ROOC
                                       CHO
                            R2                                                 OHC                   R2                              Ph
                                                   Catalyst (20 mol %)
                                                     BA(20 mol %)                                                                     Ph
         OH
                                                     DCE,rt to 350C            R3                         COOR              NH       OTMS
R1                                                                       R1
                                       CHO                                                         O
                        O   R3                                                                 O
                  NPG                                                                    NPG
Cinchona alkaloid derivatives used in this study

                                 R4            I :R1= Me, R2=OH, R3=H, R4=CH2=CH              Quinine
                                               II :R1= Me, R2=H, R3=NH2, R4=CH3CH2            Hydroquinine amine
                   R3        N                 III:R1= Ph, R2=H, R3=OH, R4=CH2=CH             Deng's catalyst 1
              R2                               IV:R1= H, R2=OBz,R3=H, R4=CH2=CH               Deng's catalyst 2
  R1O


                   N

                                                                                                           N

                                                  F3C         NH       NH                              N        N            N
F3C           NH        NH                                                          N
                                     N
                   S                                           S                        OMe      MeO

        CF3                                             CF3
                         N                                              N                                            N
                                                               VI                                              VII
              V



                                                              R                 N                      NH2               N
               NH2               N
                                                              NH       NH                              NH NH
               NH NH
                                                                   S                    OMe                S                     OMe
                    S                    OMe

                                                                            N                                        N
                             N
              X                                         VIII:R=NH2, IX:R=OH                                XI
          R-Diamine                                           S-Diamine
Entry            Cat.              SM2                Solvent           Yield(%)           d.r               e.r
1                I                 2a                 DCM               78                 91:9              40:60
2                II                2a                 DCM               65                 80:20             70:30
3                III               2a                 DCM               83                 83:17             58:42
4                IV                2a                 DCM               67                 64:36             51:49
5                V                 2a                 DCM               84                 92:8              12:88
6                VI                2a                 DCM               81                 80:20             90:10
7                VI                2a                 DCE               81                 82:18             91:9
8                VI                2a                 C6H5CN            83                 93:7              79:21
9                VI                2a                 C 6H6             86                 92:8              92:8
10§              VI                2a                 C 6H6             78                 88:12             91:9
11               VII               2a                 DCM               93                 >99:1             50:50
12               VIII              2a                 DCM               86                 91:9              95:5
13               IX                2a                 DCM               74                 90:10             86:14
14               X                 2a                 DCM               85                 91:9              90:10
15               VIII              2a                 C 6H6             79                 89:11             93:7
16               VIII              2a                 MeOH              90                 94:6              52:48
17               VIII              2a                 DCE               86                 90:10             95:5
18||             VIII              2a                 DCM               71                 88:12             91:9
19               VIII              2b                 DCM               86                 96:4              97:3
20¶              VIII              2b                 DCM               87                 96:4              97:3
         Unless otherwise specified:
        1a (0.05mol,1.0 equiv.) + 2a/2b (0.075 mol,1.5 equiv.) with 20 mol % catalyst, at room temperature (22 0C)
        § 00C, 36h ; || -150C, 48h; ¶ 15 mol% catalyst
Optimization of organocatalytic domino Michael-Aldol reaction
Analysis

Entry 1-18: Michael acceptor 2a (R=-COOMe)
Entry 1: good yield, good diastereoselectivity (d.s), moderate enantioselectivity (e.s)
-> continue examine these conditions : solvent, t0 , ratio of catalyst (20 mol %)

Entry 5,6: higher d.s and e.s ->important role of tertiary amine and thiourea group
( but entry 5 : lower e.s in relation to entry 6 -> use catalyst VI )
Entry 7-10 : slight improvements accompanied changes in solvents + decrease t0

Entry 11: complete d.s >< totally non e.s

Entry 12: trifunctional S – binaphthyl diamine (primary amine) (catalyst VIII)- > excellent result
Entry 13: trifunctional S – binaphthyl diamine (hydroxy group) -> negatve affects
Entry 14: trifunctional R – binaphthyl diamine (primary amine) -> negative affects
Entry 15-17: no significant improvements accompanied changes in solvents
Entry 18: slight drop of d.s and e.s if t0 decreased

Entry 19,20 : Michael acceptor 2b (R= -COPh)
same excellent result, ratio of used catalyst in entry 20 (15 mol%) is lower - > economy
Entry         R1                  R2               R3                Yield (%)        d.r               e.r
1             Ph                  Ph               H                 3b, 84           96:4              97:3
2             Ph                  Ph               5-F               3c, 92           97:3              97:3
3             Ph                  Ph               5-Br              3d, 87           95:5              97:3
4             Ph                  4-Cl- Ph         H                 3e, 89           96:4              97:3
5             4-F- Ph             Ph               H                 3f, 81           98:2              95:5
6             3-OMe- Ph           Ph               H                 3g, 79           95:5              98:2
7             2-Furanyl           Ph               H                 3h, 94           >99:1             97:3
8             2-Thiophenyl        Ph               H                 3i, 89           96:4              98:2
9             2-Thiophenyl        4-Cl- Ph         H                 3j, 88           >99:1             98:2
10            2-Thiophenyl        Ph               5-F               3k, 92           >99:1             98:2
11§           Ph                  2-Me- Ph         H                 3l, 69           95:5              91:9
12||          Me                  Ph               H                 3m, 56           63:37             97:3


Unless otherwise specified:
1a (0.05mol,1.0 equiv.) + 2a/2b (0.075 mol,1.5 equiv.) with 15 mol % catalyst, at room temperature (22 0C)
§ 48h ; || 12h, pure major diastereomer separated by Chomatography in 56 % yield.
Entry   R1          R2      R3     R4   Yield (%)   d.r     e.r
1       Ph          H       H      Me   3a, 78      91:9    95:5
2       3-OMe- Ph   H       H      Me   3n, 79      91:9    95:5
3       2-Furanyl   H       H      Me   3o, 86      93:7    96:4
4       Ph          H       6-Cl   Me   3p, 74      89:11   94:6
5       Ph          5-MeO   H      Me   3q, 77      88:12   96:4
6       Ph          H       H      Et   3r, 81      89:11   95:5
Investigation of a different protecting group and deprotection of Bispirooxindoles



                                                          NH2   N
                                                          NH NH
                                                            S         OMe
                 Me                                                                             NAc
                                     PhOC                       N                                           O
             O
                                                                                                      (S)    OH
                                                       15 mol% VIII                             (S)
                                                                                                               83% yield
                                                                              PhOC                          Ph 95:5 d.r
                                                                                        (S) (S)                95:5 e.r
                       O                           O   DCM, rt, 24h
                 NPG                        NAc                                                             O
                                                                                                NPG
     PG=4-Br-Bz

         4                          2b                                                      5




                                     NAc                                              NH
                                              O                                                   O
                                           (S) OH                                           (S)    OH
                                                                                      (S)
                                     (S)
                                              Ph        HCl (conc.)         PhOC                      Ph
                           PhOC                                                    (R) (S)
                                  (R) (S)
                                                       EtOH,800C,2h
                                             O                                                        O
                                      NBn                                              NBn


                            3b (97:3 e.r)                                    6 (97:3 e.r)
Proposed activation mode of catalyst and substrates

                                                S
                                                                   CHIRAL       R'
                                                                  SCAFFOLD              R''
                                            N       N                               N
                                                                        Ph
                                            H       H BnN                       H
                                                                            O
                                                                   II
                                                            O I         O       O
                                                H
                                            N           O                   N
                                                H
                                                            R




Control experiment for mechanistic studies

                Ph                                                                                      NAc
           O                      Ph                                                                             O
                                                                                                              (S) OH
                                                    15 mol% catalyst VIII                               (S)
                                                                                              Ph                 Ph
                                                                                                   (R) (S)
                     O                  O               DCM, rt, 24h
               NBn                NAc                                                                           O
                                                                                                        NBn
   PG=4-Br-Bz

       4                     2b                                                                     5

                 No reaction at all (no hydrogen bond acceptor part like ester or ketone)
Conclusion and desire of the group:

- Novel highly efficient organocatalytic construction of bispirooxindoles :
 + direct
 + using simple starting materials
 + mild conditions
 + excellent stereocontrol
 + posibility of access to the opposite enantiomer

- Ambition in future
 + expasion of applcication of the new catalyst in other assymetric transformations
 + investagation of biological activity of compound synthesized
- > hopefully novel lead and therapeutic agents

Más contenido relacionado

La actualidad más candente

Molbiol 2011-10-proteins
Molbiol 2011-10-proteinsMolbiol 2011-10-proteins
Molbiol 2011-10-proteins
Nikolay Vyahhi
 
Cwa Invited Talk Fei Pittcon 2009
Cwa Invited Talk Fei Pittcon 2009Cwa Invited Talk Fei Pittcon 2009
Cwa Invited Talk Fei Pittcon 2009
inscore
 

La actualidad más candente (20)

123.202 Lecture 7 - alkenes
123.202 Lecture 7 - alkenes123.202 Lecture 7 - alkenes
123.202 Lecture 7 - alkenes
 
Lecture4: 123.702
Lecture4: 123.702Lecture4: 123.702
Lecture4: 123.702
 
Lecture9:123.702
Lecture9:123.702Lecture9:123.702
Lecture9:123.702
 
Lecture8: 123.702
Lecture8: 123.702Lecture8: 123.702
Lecture8: 123.702
 
Molbiol 2011-10-proteins
Molbiol 2011-10-proteinsMolbiol 2011-10-proteins
Molbiol 2011-10-proteins
 
Lecture2: 123.702
Lecture2: 123.702Lecture2: 123.702
Lecture2: 123.702
 
Lecture8: 123.312
Lecture8: 123.312Lecture8: 123.312
Lecture8: 123.312
 
Tsvaygboym, Arkivoc, 2003, v12, pp89-109
Tsvaygboym, Arkivoc, 2003, v12, pp89-109Tsvaygboym, Arkivoc, 2003, v12, pp89-109
Tsvaygboym, Arkivoc, 2003, v12, pp89-109
 
123.202 Lecture 11 - alkynes
123.202 Lecture 11 - alkynes123.202 Lecture 11 - alkynes
123.202 Lecture 11 - alkynes
 
BITS - Introduction to Mass Spec data generation
BITS - Introduction to Mass Spec data generationBITS - Introduction to Mass Spec data generation
BITS - Introduction to Mass Spec data generation
 
Lecture3: 123.312
Lecture3: 123.312Lecture3: 123.312
Lecture3: 123.312
 
Postgraduate Research @ Mayo Clinic Jacksonville
Postgraduate Research @ Mayo Clinic JacksonvillePostgraduate Research @ Mayo Clinic Jacksonville
Postgraduate Research @ Mayo Clinic Jacksonville
 
Lecture2: 123.312
Lecture2: 123.312Lecture2: 123.312
Lecture2: 123.312
 
Cwa Invited Talk Fei Pittcon 2009
Cwa Invited Talk Fei Pittcon 2009Cwa Invited Talk Fei Pittcon 2009
Cwa Invited Talk Fei Pittcon 2009
 
Lecture7: 123.312
Lecture7: 123.312Lecture7: 123.312
Lecture7: 123.312
 
123.202 Lecture 8 - alkenes
123.202 Lecture 8 - alkenes123.202 Lecture 8 - alkenes
123.202 Lecture 8 - alkenes
 
Lecture4: 123.312
Lecture4: 123.312Lecture4: 123.312
Lecture4: 123.312
 
123.202 Lecture 9 - alkenes
123.202 Lecture 9 - alkenes123.202 Lecture 9 - alkenes
123.202 Lecture 9 - alkenes
 
Phytoquest ppt
Phytoquest  pptPhytoquest  ppt
Phytoquest ppt
 
Chapter8醇
Chapter8醇Chapter8醇
Chapter8醇
 

Similar a Single multifunctional organocatalyst

Eln 296571 seminar v 5b
Eln 296571 seminar v 5bEln 296571 seminar v 5b
Eln 296571 seminar v 5b
David Quincy
 
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of PharmacyIOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
iosrphr_editor
 
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of PharmacyIOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
iosrphr_editor
 
Mannich reaction (1)
Mannich reaction (1)Mannich reaction (1)
Mannich reaction (1)
Shreesha Bhat
 
Chapter 11 dna biology &amp; technology
Chapter 11 dna biology &amp; technologyChapter 11 dna biology &amp; technology
Chapter 11 dna biology &amp; technology
cetla1
 
1.[1 9]use of 2-{[5-(2-amino-4-oxoquinazolin-3(4 h)-yl)-1,3,4-thiadiazol-2-yl...
1.[1 9]use of 2-{[5-(2-amino-4-oxoquinazolin-3(4 h)-yl)-1,3,4-thiadiazol-2-yl...1.[1 9]use of 2-{[5-(2-amino-4-oxoquinazolin-3(4 h)-yl)-1,3,4-thiadiazol-2-yl...
1.[1 9]use of 2-{[5-(2-amino-4-oxoquinazolin-3(4 h)-yl)-1,3,4-thiadiazol-2-yl...
Alexander Decker
 
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
iosrphr_editor
 
Lessons learned - the pharma experience
Lessons learned  - the pharma experienceLessons learned  - the pharma experience
Lessons learned - the pharma experience
DESCA_2012
 
Carbonyl assignment step growth polymer2
Carbonyl assignment step growth polymer2Carbonyl assignment step growth polymer2
Carbonyl assignment step growth polymer2
hani1989
 

Similar a Single multifunctional organocatalyst (20)

Eln 296571 seminar v 5b
Eln 296571 seminar v 5bEln 296571 seminar v 5b
Eln 296571 seminar v 5b
 
Collision induced dissociative chemical cross-linking reagent for protein str...
Collision induced dissociative chemical cross-linking reagent for protein str...Collision induced dissociative chemical cross-linking reagent for protein str...
Collision induced dissociative chemical cross-linking reagent for protein str...
 
Postdoctoral Research @ NAWCWD
Postdoctoral Research @ NAWCWDPostdoctoral Research @ NAWCWD
Postdoctoral Research @ NAWCWD
 
Beckmann
BeckmannBeckmann
Beckmann
 
Lecture5: 123.702
Lecture5: 123.702Lecture5: 123.702
Lecture5: 123.702
 
Heterocycles 3
Heterocycles 3Heterocycles 3
Heterocycles 3
 
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of PharmacyIOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
 
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of PharmacyIOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
 
Literature Review-copyright
Literature Review-copyrightLiterature Review-copyright
Literature Review-copyright
 
Mannich reaction (1)
Mannich reaction (1)Mannich reaction (1)
Mannich reaction (1)
 
Chapter 11 dna biology &amp; technology
Chapter 11 dna biology &amp; technologyChapter 11 dna biology &amp; technology
Chapter 11 dna biology &amp; technology
 
1.[1 9]use of 2-{[5-(2-amino-4-oxoquinazolin-3(4 h)-yl)-1,3,4-thiadiazol-2-yl...
1.[1 9]use of 2-{[5-(2-amino-4-oxoquinazolin-3(4 h)-yl)-1,3,4-thiadiazol-2-yl...1.[1 9]use of 2-{[5-(2-amino-4-oxoquinazolin-3(4 h)-yl)-1,3,4-thiadiazol-2-yl...
1.[1 9]use of 2-{[5-(2-amino-4-oxoquinazolin-3(4 h)-yl)-1,3,4-thiadiazol-2-yl...
 
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
 
Wolf rearrangement
Wolf rearrangementWolf rearrangement
Wolf rearrangement
 
Chemist talks to class of 5th graders
Chemist talks to class of 5th gradersChemist talks to class of 5th graders
Chemist talks to class of 5th graders
 
Tetracycline
TetracyclineTetracycline
Tetracycline
 
Stability techniques
Stability techniquesStability techniques
Stability techniques
 
Nucleotide METABOLISM MUHAMMAD MUSTANSAR
Nucleotide  METABOLISM  MUHAMMAD MUSTANSARNucleotide  METABOLISM  MUHAMMAD MUSTANSAR
Nucleotide METABOLISM MUHAMMAD MUSTANSAR
 
Lessons learned - the pharma experience
Lessons learned  - the pharma experienceLessons learned  - the pharma experience
Lessons learned - the pharma experience
 
Carbonyl assignment step growth polymer2
Carbonyl assignment step growth polymer2Carbonyl assignment step growth polymer2
Carbonyl assignment step growth polymer2
 

Último

+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
?#DUbAI#??##{{(☎️+971_581248768%)**%*]'#abortion pills for sale in dubai@
 
Why Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire businessWhy Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire business
panagenda
 
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Victor Rentea
 
Architecting Cloud Native Applications
Architecting Cloud Native ApplicationsArchitecting Cloud Native Applications
Architecting Cloud Native Applications
WSO2
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Safe Software
 

Último (20)

+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
 
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot TakeoffStrategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
 
Why Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire businessWhy Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire business
 
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost SavingRepurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
 
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWEREMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
 
Corporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptxCorporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptx
 
Boost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdfBoost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdf
 
Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024
 
Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin WoodPolkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
 
How to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected WorkerHow to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected Worker
 
MS Copilot expands with MS Graph connectors
MS Copilot expands with MS Graph connectorsMS Copilot expands with MS Graph connectors
MS Copilot expands with MS Graph connectors
 
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdfRising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
 
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
 
Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...
 
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
 
Spring Boot vs Quarkus the ultimate battle - DevoxxUK
Spring Boot vs Quarkus the ultimate battle - DevoxxUKSpring Boot vs Quarkus the ultimate battle - DevoxxUK
Spring Boot vs Quarkus the ultimate battle - DevoxxUK
 
Architecting Cloud Native Applications
Architecting Cloud Native ApplicationsArchitecting Cloud Native Applications
Architecting Cloud Native Applications
 
MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
 
Cyberprint. Dark Pink Apt Group [EN].pdf
Cyberprint. Dark Pink Apt Group [EN].pdfCyberprint. Dark Pink Apt Group [EN].pdf
Cyberprint. Dark Pink Apt Group [EN].pdf
 

Single multifunctional organocatalyst

  • 1. Using a single multifunctional organocatalyst in a single-step construction of bispirooxindoles with 3 quaternary stereocentres LY-NGUYEN Hai Du - 31/10 Tan, B., Candeias, N. R, & Barbas, C. F. Nat. Chem. 2011, 3, 473
  • 2. BISPIROOXINDOLES, WHY? Spirocyclicooxindole scaffold F Cl H H N H N OH N HN NH NHMe NO2 H H N O O O OMeN N N Cl N MeO N HO H H H O O O Strychnofoline NITD609 Citrinadin B Cyclopiamine B Sructural features: > = 1 C */ enantiomerically pure backbone => efficient asymmetric synthetic methods IN REALITY??? Few transformations meet this requirement Ar Cycloaddition processes O O P R4 OH R2 O NH Ar R2 CO2R6 R5 Ar = -Naphthyl R5 R4 CHO R1 O R1 O H2N CO2R6 CH2Cl2 ,RT, N N R3 R3 Up to 98% ee Intramolecular Heck reactions CO2Me Cyclohexen CO2Me Pd(OAc)2, (R ) - BINAP I Ag2CO3, NMP,600C H About 46% ee
  • 3.
  • 4. Inherent benefits of using organic molecules as catalysts ? - available from bio-matter - intensitive to moisture and air - non-toxic - inexpensive and operationally easy to handle - rich ??? Generic mode of activation commonly used in organocatalysis Iminium catalysis Enamine catalysis O N+ N+ more electrophilic O N NH H H H H R' - H2O R' R' - H2O R' R R R R more acidic more nucleophilic more electrophilic H-bonding catalysis S S X N N NH NH H H R R' X X= O,NR R,R',R''= alkyl, aryl R R' more electrophilic
  • 5. Inherent benefits of using organic molecules as catalysts ? - available from bio-matter - intensitive to moisture and air - non-toxic - inexpensive and operationally easy to handle - rich ??? Generic mode of activation commonly used in organocatalysis Iminium catalysis Enamine catalysis O N+ N+ more electrophilic O N NH H H H H R' - H2O R' R' - H2O R' R R R R more acidic more nucleophilic more electrophilic H-bonding catalysis S S X N N NH NH H H R R' X X= O,NR R,R',R''= alkyl, aryl R R' more electrophilic
  • 6. Cinchona alkaloid derivatives activate electrophile OMe OMe 6' 6' OH OH 4' N N 4' 9 8 8 9 N H H N Quinidine Quinie activate activate nucleophile electrophile activate electrophile OH OH OH OH 6' 6' 6' 6' OR OR O NH2 4' N N 4' 4' N 4' N 9 8 8 9 9 9 8 8 N H H N N N H QD-1 Q-1 activate QD-3 activate QD-2 nucleophile nucleophile Deng et al., 2004 Addition 1,4 of malonates to nitroolefins COOMe COOMe NO2 QD-1/Q-1(10mol%) 97-99% yield, R COOMe COOMe NO2 93-96% ee 0 THF,-20 C,36h R R=aryl, heteroaryl O O OH O Baylis-Hilman reaction QD-2 R1 H R2 R1 R2 Guofu Zhong et al. , 2008 R1 O O O O Michael-Henry reaction QD-3 O R1 NO2 R 85% =94% yield O R up to 99 .99% ee NO2 up to 99:1 dr O OH
  • 7.
  • 8. 3-substituted oxindoles - efficient Michael donors F3C Maruoka et al, 2009 O Catalyst CF3 Br Bu O P Catalyst (1-3mol %) Toluen Bu O O Potassium benzoate N 2-18h,-60-00 C N CF3 Boc Boc >96% yield, 90-99%ee F3C Barbas et al, 2009 R1 Catalyst S R R NO2 Ar NH NH Catalyst (10 mol %) NO2 O N O R1 Ar (CH2)3 (CH2)3 Ar CF3 CHCl3, 24h, -200 C N N Ar= Boc Boc R=alkyl R1=aryl, heteroaryl >90%yield, >90% ee CF3 Methyleneidolinones - highly reactive Michael acceptors Chung Chen et al, 2009 Catalyst ROOC CHO R2 OHC R2 Ph Catalyst (20 mol %) BA(20 mol %) Ph OH DCE,rt to 350C R3 COOR NH OTMS R1 R1 CHO O O R3 O NPG NPG
  • 9. Cinchona alkaloid derivatives used in this study R4 I :R1= Me, R2=OH, R3=H, R4=CH2=CH Quinine II :R1= Me, R2=H, R3=NH2, R4=CH3CH2 Hydroquinine amine R3 N III:R1= Ph, R2=H, R3=OH, R4=CH2=CH Deng's catalyst 1 R2 IV:R1= H, R2=OBz,R3=H, R4=CH2=CH Deng's catalyst 2 R1O N N F3C NH NH N N N F3C NH NH N N S S OMe MeO CF3 CF3 N N N VI VII V R N NH2 N NH2 N NH NH NH NH NH NH S OMe S OMe S OMe N N N X VIII:R=NH2, IX:R=OH XI R-Diamine S-Diamine
  • 10. Entry Cat. SM2 Solvent Yield(%) d.r e.r 1 I 2a DCM 78 91:9 40:60 2 II 2a DCM 65 80:20 70:30 3 III 2a DCM 83 83:17 58:42 4 IV 2a DCM 67 64:36 51:49 5 V 2a DCM 84 92:8 12:88 6 VI 2a DCM 81 80:20 90:10 7 VI 2a DCE 81 82:18 91:9 8 VI 2a C6H5CN 83 93:7 79:21 9 VI 2a C 6H6 86 92:8 92:8 10§ VI 2a C 6H6 78 88:12 91:9 11 VII 2a DCM 93 >99:1 50:50 12 VIII 2a DCM 86 91:9 95:5 13 IX 2a DCM 74 90:10 86:14 14 X 2a DCM 85 91:9 90:10 15 VIII 2a C 6H6 79 89:11 93:7 16 VIII 2a MeOH 90 94:6 52:48 17 VIII 2a DCE 86 90:10 95:5 18|| VIII 2a DCM 71 88:12 91:9 19 VIII 2b DCM 86 96:4 97:3 20¶ VIII 2b DCM 87 96:4 97:3 Unless otherwise specified: 1a (0.05mol,1.0 equiv.) + 2a/2b (0.075 mol,1.5 equiv.) with 20 mol % catalyst, at room temperature (22 0C) § 00C, 36h ; || -150C, 48h; ¶ 15 mol% catalyst
  • 11. Optimization of organocatalytic domino Michael-Aldol reaction Analysis Entry 1-18: Michael acceptor 2a (R=-COOMe) Entry 1: good yield, good diastereoselectivity (d.s), moderate enantioselectivity (e.s) -> continue examine these conditions : solvent, t0 , ratio of catalyst (20 mol %) Entry 5,6: higher d.s and e.s ->important role of tertiary amine and thiourea group ( but entry 5 : lower e.s in relation to entry 6 -> use catalyst VI ) Entry 7-10 : slight improvements accompanied changes in solvents + decrease t0 Entry 11: complete d.s >< totally non e.s Entry 12: trifunctional S – binaphthyl diamine (primary amine) (catalyst VIII)- > excellent result Entry 13: trifunctional S – binaphthyl diamine (hydroxy group) -> negatve affects Entry 14: trifunctional R – binaphthyl diamine (primary amine) -> negative affects Entry 15-17: no significant improvements accompanied changes in solvents Entry 18: slight drop of d.s and e.s if t0 decreased Entry 19,20 : Michael acceptor 2b (R= -COPh) same excellent result, ratio of used catalyst in entry 20 (15 mol%) is lower - > economy
  • 12. Entry R1 R2 R3 Yield (%) d.r e.r 1 Ph Ph H 3b, 84 96:4 97:3 2 Ph Ph 5-F 3c, 92 97:3 97:3 3 Ph Ph 5-Br 3d, 87 95:5 97:3 4 Ph 4-Cl- Ph H 3e, 89 96:4 97:3 5 4-F- Ph Ph H 3f, 81 98:2 95:5 6 3-OMe- Ph Ph H 3g, 79 95:5 98:2 7 2-Furanyl Ph H 3h, 94 >99:1 97:3 8 2-Thiophenyl Ph H 3i, 89 96:4 98:2 9 2-Thiophenyl 4-Cl- Ph H 3j, 88 >99:1 98:2 10 2-Thiophenyl Ph 5-F 3k, 92 >99:1 98:2 11§ Ph 2-Me- Ph H 3l, 69 95:5 91:9 12|| Me Ph H 3m, 56 63:37 97:3 Unless otherwise specified: 1a (0.05mol,1.0 equiv.) + 2a/2b (0.075 mol,1.5 equiv.) with 15 mol % catalyst, at room temperature (22 0C) § 48h ; || 12h, pure major diastereomer separated by Chomatography in 56 % yield.
  • 13. Entry R1 R2 R3 R4 Yield (%) d.r e.r 1 Ph H H Me 3a, 78 91:9 95:5 2 3-OMe- Ph H H Me 3n, 79 91:9 95:5 3 2-Furanyl H H Me 3o, 86 93:7 96:4 4 Ph H 6-Cl Me 3p, 74 89:11 94:6 5 Ph 5-MeO H Me 3q, 77 88:12 96:4 6 Ph H H Et 3r, 81 89:11 95:5
  • 14.
  • 15. Investigation of a different protecting group and deprotection of Bispirooxindoles NH2 N NH NH S OMe Me NAc PhOC N O O (S) OH 15 mol% VIII (S) 83% yield PhOC Ph 95:5 d.r (S) (S) 95:5 e.r O O DCM, rt, 24h NPG NAc O NPG PG=4-Br-Bz 4 2b 5 NAc NH O O (S) OH (S) OH (S) (S) Ph HCl (conc.) PhOC Ph PhOC (R) (S) (R) (S) EtOH,800C,2h O O NBn NBn 3b (97:3 e.r) 6 (97:3 e.r)
  • 16. Proposed activation mode of catalyst and substrates S CHIRAL R' SCAFFOLD R'' N N N Ph H H BnN H O II O I O O H N O N H R Control experiment for mechanistic studies Ph NAc O Ph O (S) OH 15 mol% catalyst VIII (S) Ph Ph (R) (S) O O DCM, rt, 24h NBn NAc O NBn PG=4-Br-Bz 4 2b 5 No reaction at all (no hydrogen bond acceptor part like ester or ketone)
  • 17. Conclusion and desire of the group: - Novel highly efficient organocatalytic construction of bispirooxindoles : + direct + using simple starting materials + mild conditions + excellent stereocontrol + posibility of access to the opposite enantiomer - Ambition in future + expasion of applcication of the new catalyst in other assymetric transformations + investagation of biological activity of compound synthesized - > hopefully novel lead and therapeutic agents